Vontobel Holding
GILD icon

Vontobel Holding’s Gilead Sciences GILD Stock Holding History

Vontobel Holding’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150,000
Closed -$10.2M – 1036
2020
Q4 		$10.2M Buy
+150,000
New +$9.05M 0.07% 172

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vontobel Holding's GILD Position: Q1 2026 in Review

Vontobel Holding increased its Gilead Sciences (GILD) stake by 30% in Q1 2026, buying an estimated $29.2M and bringing the position to 906,295 shares worth $126M. The position accounts for 0.43% of the portfolio, ranked #58.

Vontobel Holding first reported a position in GILD in Q4 2020 and has held it in 22 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Vontobel Holding held 906,295 shares of Gilead Sciences worth $126M as of Q1 2026.
  • Vontobel Holding bought 208,564 Gilead Sciences shares in Q1 2026, an estimated $29.2M.
  • Gilead Sciences made up 0.43% of Vontobel Holding's portfolio in Q1 2026, its #58 holding.
  • Vontobel Holding first reported a position in Gilead Sciences in Q4 2020 and has held it in 22 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.